Significance of voxel-based morphometry in studying mild cognitive impairments

Cover Page


Cite item

Full Text

Abstract

Cognitive impairments are an important medical and social problem associated with a high prevalence of this disease in the population. 46% of patients develop dementia within 5 years after the diagnosis of mild cognitive impairments (MCIs). Voxelbased morphometry (VBM) is a modern neuroimaging technique well-proven in studying dementia. VBM in a combination with neuropsychological examination of patients enables clarifying the genesis of mild cognitive impairments (MCIs) and predicting further development of the disease as early as the initial stage of the pathology.

About the authors

A. I. Damulina

Research Center of Neurology

Author for correspondence.
Email: damulinaanna@gmail.com
Россия, Moscow

Rodion N. Konovalov

Research Center of Neurology

Email: damulinaanna@gmail.com
ORCID iD: 0000-0001-5539-245X

Cand. Sci. (Med.), senior researcher, Neuroradiology department

Россия, 125367 Moscow, Volokolamskoye shosse, 80

A. S. Kadykov

Research Center of Neurology

Email: damulinaanna@gmail.com
Россия, Moscow

References

  1. Блейхер В.М., Крук И.В., Боков. С.Н. Клиническая патопсихология: руководство для врачей и клинических психологов. М.: Изд-во Московского психолого-социального института, 2006. 624 с.
  2. Дамулин И.В. Когнитивные расстройства. Некоторые вопросы клиники, диагностики, лечения. М., 2012. 19 с.
  3. Дамулина А.И., Кадыков А.С. Когнитивные нарушения при хронической ишемии головного мозга. Фарматека. 2014; 10: 63–69.
  4. Деменция: приоритет общественного здравоохранения. ВОЗ;Международная организация по проблемам болезни Альцгеймера. 2013: 2–8.
  5. Колесниченко Ю.А., Машин В.В., Иллариошкин С.Н. и др. Воксел-ориентированная морфометрия: новый метод оценки локальных вторичных атрофических изменений головного мозга. Анн. клинич. и эксперим. неврологии. 2007; 1 (4): 36.
  6. Леонтьев А. Развитие памяти. Москва: Государственное медико-педагогическое издательство, 1931: 82–99.
  7. Полунина А.Г., Брюн Е.А. Эпизодическая память: неврологические и нейромедиаторные механизмы. Анн. клинич. и эксперим. неврологии. 2012; 6 (3): 53–61.
  8. Шахпаронова Н.В., Кашина Е.М., Кадыков А.С. Когнитивные нарушения у постинсультных больных с глубокой локализацией полушарного очага. Анн. клинич. и эксперим. неврологии. 2010;4 (3): 4–10.
  9. Alberta M., De Koskyb S., Dicksond D. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement .2011 May;7 (3): 270–279.
  10. de Leon M., Golomb J., Convit A. et al. Measurement of medial temporal lobe atrophy in diagnosis of Alzheimer’s disease. Lancet 1993 Jan 9; 341 (8837): 125–126.
  11. Fernando M., Ince P. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 2004; 226 (1–20):13–17.
  12. Frisoni G., Testa C., Zorzan A. et al. Detection of grey matter loss in mild Alzheimer’s disease with voxel based morphometry. J Neurol Neurosurg Psychiatry. 2002 Dec; 73 (6): 657–664.
  13. Horinek D., Varjassyova A., Hort J. Magnetic resonance analysis of amygdalaar volume in Alzheimer’s disease. Curr Opin Psychiatry. 2007 May; 20 (3): 273–277.http://www.dsm5.org
  14. Jellinger K. The enigma of mixed dementia. Alzheimer Dement 2007; 3 (1): 40–53.
  15. Jelinger K., Attems J. Neuropathological evolution of mixed dementia. J NeurolSci 2007; 257 (1–2): 80–87.
  16. Karas G., Scheltens P., Rombouts S. et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer’s disease. Neuroimage. 2004 Oct; 23 (2): 708–716.
  17. Kordower J., Chu Y., Stebbins G. et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001 Feb; 49 (2): 202–213.
  18. Li C., Du H., Zheng J. et al. A voxel-based morphometric analysis
  19. of cerebral gray matter in subcortical ischemic vascular dementia patients and normal aged controls. Int J Med Sci. 2011; 8 (6): 482–486.
  20. Lim A., Tsuang D., Kukull W. et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am GeriatrSoc 1999; 47 (5): 564–569.
  21. McKhann G., Drachman D., Folstein M. et al. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984; 34: 939–944.
  22. Nasreddine Z., Phillips N., Bédirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53 (4): 695–699.
  23. Nyenhuis D., Gorelick P.B.: Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment. J of the American Geriatrics Society 1998, 46:1437–1448.
  24. Pennanen C., Kivipelto M., Tuomainen S. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 2004 Mar; 25 (3): 303–310.
  25. Petersen R.C., Smith G.E., Waring S.C. et al. Mild cognitive impairment: clinical characterization and outcome. Archives of neurology. 1999; 56 (3): 303–308.
  26. Pihlajamäki M., Jauhiainen A., Soininen H. Structural and functional MRI in mild cognitive impairment. Curr Alzheimer Res, 2009 Apr; 6 (2):179–185.
  27. Quinque E., Arélin K., Dukart J. Identifying the neural correlates of executive functions in early cerebral microangiopathy: a combined VBM and DTI study. J Cereb Blood Flow Metab. 2012 Oct; 32 (10):1869–1878.
  28. Rockwood K., Song X., MacKnight C. et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489–495.
  29. Rockwood K., Wentzel C., Hachinski V. et al. Prevalence and outcomes of vascular cognitive impairment. Vascular cognitive impairment investigators of the Canadian study of health and aging. Neurology. 2000; 54: 447–4451.
  30. Rosen W., Mohs R., Davis K. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984; 141: 1356–1364.
  31. Scheltens P., Leys D., Barkhof F. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J NeurolNeurosurg Psychiatry. 1992 Oct; 55 (10): 967–972.
  32. Schmidt-Wilcke T., Poljansky S., Hierlmeier S. et al. Memory performance correlates with grey matter density in the ento-/perirhinal cortex and posterior hippocampus in patients with mild cognitive impairment and healthy controls – a voxel based morphometry study. Neuroimage 2009 Oct 1; 47 (4): 1914–1920.
  33. Schneider J., Arvanitakis Z., Bang W. et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007; 69 (24): 2197–2204.
  34. Starkstein S.E., Sabe S., Vasquez S. et al.: Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer’s disease. Stroke 1996, 7: 408–414.
  35. Wentzel C., Rockwood K. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001 Aug 28; 57 (4): 714–716.
  36. Yi L., Wang J., Jia L. et al. Structural and functional changes in subcortical vascular mild cognitive impairment: a combined voxel-based morphometry and resting-state fMRI study. PLos One. 2012; 7 (9): e44758.
  37. Zekry D., Hauw J., Gold G. Mixed dementia: epidemiology, diagnosis and treatment. J Am GeriatrSoc 2002; 50 (8): 1431–1438.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Damulina A.I., Konovalov R.N., Kadykov A.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies